Literature DB >> 22602841

Mycobacterium malmoense: dissemination causes a popliteal aneurysm in a 74-year-old man.

Andrew Stewart Brereton1, Hassan El Teraifi.   

Abstract

Mycobacterium malmoense is recognised as an environmental pathogen predominantly affecting populations in Northern Europe. In immuno-competent individuals, isolated pulmonary disease remains the commonest presentation. The authors report a rare case describing a mycotic popliteal aneurysm caused by M malmoense in a 74-year-old man from Hastings, UK with co-existing pulmonary M malmoense disease. Primary pulmonary disease was confirmed by a combination of history, examination and positive radiological and microbiological findings. Tissue analysis of the aneurysm wall during popliteal aneurysm repair confirmed the presence of disseminated M malmoense. Histological analysis of the aneurysm wall showed non-caseating granulomata. The patient completed a 2 year course of rifampicin, ethambutol and clarithromycin which eradicated the organism from his sputum. Further progress has been complicated by the development of an aspergilloma at the site of his eradicated pulmonary M malmoense disease and the need for angioplasty to his bypass grafts 1 year postsurgery.

Entities:  

Mesh:

Year:  2012        PMID: 22602841      PMCID: PMC3339186          DOI: 10.1136/bcr.12.2011.5471

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

3.  Treatment of pulmonary aspergilloma with itraconazole.

Authors:  J H Campbell; J H Winter; M D Richardson; G S Shankland; S W Banham
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

4.  Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex.

Authors:  M D Iseman; D L Buschman; L M Ackerson
Journal:  Am Rev Respir Dis       Date:  1991-10

Review 5.  Extrapulmonary and disseminated infections due to Mycobacterium malmoense: case report and review.

Authors:  M Zaugg; M Salfinger; M Opravil; R Lüthy
Journal:  Clin Infect Dis       Date:  1993-04       Impact factor: 9.079

6.  Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.

Authors:  S E Hoffner; U Hjelm; G Källenius
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

Review 7.  Pulmonary disease due to nontuberculous mycobacteria.

Authors:  Jeffrey Glassroth
Journal:  Chest       Date:  2008-01       Impact factor: 9.410

8.  Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.

Authors:  P A Jenkins; I A Campbell; J Banks; C M Gelder; R J Prescott; A P Smith
Journal:  Thorax       Date:  2008-02-04       Impact factor: 9.139

  8 in total
  1 in total

1.  Mycobacterium malmoense pulmonary infection in France: a case report.

Authors:  Simon Grandjean Lapierre; Mustapha Fellag; Célia Magan; Michel Drancourt
Journal:  BMC Res Notes       Date:  2017-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.